206 related articles for article (PubMed ID: 18717189)
1. Efficacy of latanoprost when stored at room temperature.
Mochizuki H; Itakura H; Takamatsu M; Kiuchi Y
Hiroshima J Med Sci; 2008 Jun; 57(2):69-72. PubMed ID: 18717189
[TBL] [Abstract][Full Text] [Related]
2. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
[TBL] [Abstract][Full Text] [Related]
3. Effect of 15-keto latanoprost on intraocular pressure and aqueous humor dynamics in monkey eyes.
Wang RF; Gagliuso DJ; Mittag TW; Podos SM
Invest Ophthalmol Vis Sci; 2007 Sep; 48(9):4143-7. PubMed ID: 17724199
[TBL] [Abstract][Full Text] [Related]
4. Effect of latanoprost on the diurnal variations in the intraocular and ocular perfusion pressure in normal tension glaucoma.
Ishibashi S; Hirose N; Tawara A; Kubota T
J Glaucoma; 2006 Oct; 15(5):354-7. PubMed ID: 16988595
[TBL] [Abstract][Full Text] [Related]
5. Effects of travoprost 0.004% ophthalmic solution, six weeks after its laminated packaging had been removed, in primary open-angle glaucoma: a randomized, controlled, investigator-blinded study.
Reis R; dos Santos LC; Vila MP; Magacho L
Clin Ther; 2004 Dec; 26(12):2121-7. PubMed ID: 15823775
[TBL] [Abstract][Full Text] [Related]
6. Reduction of intraocular pressure in mouse eyes treated with latanoprost.
Aihara M; Lindsey JD; Weinreb RN
Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):146-50. PubMed ID: 11773025
[TBL] [Abstract][Full Text] [Related]
7. Comparison of twice-daily and three-times-daily dosing of dorzolamide in ocular hypertension and primary open-angle glaucoma patients treated with latanoprost.
Lupinacci AP; Netland PA; Fung KH; Evans D; Zhao Y
Adv Ther; 2008 Mar; 25(3):231-9. PubMed ID: 18369537
[TBL] [Abstract][Full Text] [Related]
8. Twenty-four-hour intraocular pressure and blood pressure levels with bimatoprost versus latanoprost in patients with normal-tension glaucoma.
Quaranta L; Pizzolante T; Riva I; Haidich AB; Konstas AG; Stewart WC
Br J Ophthalmol; 2008 Sep; 92(9):1227-31. PubMed ID: 18586898
[TBL] [Abstract][Full Text] [Related]
9. Effect of topical ophthalmic latanoprost on intraocular pressure in normal horses.
Davidson HJ; Pinard CL; Keil SM; Brightman AH; Sargeant JM
Vet Ther; 2002; 3(1):72-80. PubMed ID: 12050830
[TBL] [Abstract][Full Text] [Related]
10. Discrepancy of the intraocular pressure response between fellow eyes in one-eye trials versus bilateral treatment: verification with normal subjects.
Takahashi M; Higashide T; Sakurai M; Sugiyama K
J Glaucoma; 2008; 17(3):169-74. PubMed ID: 18414100
[TBL] [Abstract][Full Text] [Related]
11. The effect of latanoprost, bimatoprost, and travoprost on circadian variation of intraocular pressure in patients with open-angle glaucoma.
Yildirim N; Sahin A; Gultekin S
J Glaucoma; 2008; 17(1):36-9. PubMed ID: 18303382
[TBL] [Abstract][Full Text] [Related]
12. Second-line therapy with dorzolamide/timolol or latanoprost/timolol fixed combination versus adding dorzolamide/timolol fixed combination to latanoprost monotherapy.
Konstas AG; Mikropoulos D; Dimopoulos AT; Moumtzis G; Nelson LA; Stewart WC
Br J Ophthalmol; 2008 Nov; 92(11):1498-502. PubMed ID: 18703549
[TBL] [Abstract][Full Text] [Related]
13. Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma.
Nakamoto K; Yasuda N
J Glaucoma; 2007; 16(4):352-7. PubMed ID: 17570997
[TBL] [Abstract][Full Text] [Related]
14. Effects of travoprost 0.004% compared with latanoprost 0.005% on the intraocular pressure of normal dogs.
Carvalho AB; Laus JL; Costa VP; Barros PS; Silveira PR
Vet Ophthalmol; 2006; 9(2):121-5. PubMed ID: 16497237
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of bimatoprost as replacement for latanoprost in patients with glaucoma or ocular hypertension: a uniocular switch study.
Casson RJ; Liu L; Graham SL; Morgan WH; Grigg JR; Galanopoulos A; Crawford A; House PH
J Glaucoma; 2009; 18(8):582-8. PubMed ID: 19826386
[TBL] [Abstract][Full Text] [Related]
16. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
Ota T; Murata H; Sugimoto E; Aihara M; Araie M
Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.
Tofflemire KL; Whitley EM; Allbaugh RA; Ben-Shlomo G; Robinson CC; Overton TL; Thiessen CE; Evans EA; Griggs AN; Adelman SA; Ludwig AL; Jens JK; Ellinwood NM; Peterson CS; Whitley RD
Am J Vet Res; 2015 Jul; 76(7):625-31. PubMed ID: 26111092
[TBL] [Abstract][Full Text] [Related]
18. Comparing diurnal and nocturnal effects of brinzolamide and timolol on intraocular pressure in patients receiving latanoprost monotherapy.
Liu JH; Medeiros FA; Slight JR; Weinreb RN
Ophthalmology; 2009 Mar; 116(3):449-54. PubMed ID: 19157559
[TBL] [Abstract][Full Text] [Related]
19. Topical and oral ketorolac administration increases the intraocular pressure-lowering effect of latanoprost.
Costagliola C; Campa C; Perri P; Parmeggiani F; Romano MR; Incorvaia C
Curr Eye Res; 2008 May; 33(5):477-82. PubMed ID: 18568885
[TBL] [Abstract][Full Text] [Related]
20. Effects of the timolol-dorzolamide fixed combination and latanoprost on circadian diastolic ocular perfusion pressure in glaucoma.
Quaranta L; Miglior S; Floriani I; Pizzolante T; Konstas AG
Invest Ophthalmol Vis Sci; 2008 Oct; 49(10):4226-31. PubMed ID: 18502991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]